![DNA Sequencing Data Processing Genetic Genomic Analysis](/sites/default/files/styles/medium/public/2024-04/GettyImages-1293619871_0.jpg?itok=u48lenCi)
Diversity in Clinical Trials
Overview
The underrepresentation of diverse groups in clinical research, mistrust in research, and the lack of diversity in the health workforce play significant roles in the persistence of health inequities. FasterCures aims to develop strategies and policies to increase diversity and inclusion in all stages of clinical research and to change the culture of systems within the biomedical research community to value diversity and representation in the development and execution of clinical trials.
Health Economics Driving New Investments
Panelists first explore the economic and financial toll of health inequities in hindering access to affordable health care, including drugs and treatments as well as participation in clinical trials. Conversely, they review measures that policymakers and industry—particularly within the C-suite—can take to effect meaningful change in making the health-care and research ecosystem more equitable and affordable.
![Decorative](/sites/default/files/styles/spotlight_665_x_510/public/2024-08/1433_Health%20Economics%20Driving%20New%20Investments%20Thumbnail.jpg?itok=L6fxqcBL)